Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN:US

159.5900 USD 1.0300 0.65%

As of 13:35:43 ET on 03/04/2015.

Snapshot for Amgen Inc (AMGN)

Open: 157.8400 Day's Range: 156.8100 - 159.6100 Volume: 1,843,350
Previous Close: 158.5600 52wk Range: 108.2000 - 173.1400 1-Yr Rtn: +28.99%

Stock Chart for AMGN

No chart data available.
  • AMGN:US 159.6000
  • 1D
  • 1M
  • 1Y
158.5600
Interactive AMGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMGN

Current P/E Ratio (ttm) 20.9958
Estimated P/E(12/2015) 17.0764
Relative P/E vs. SPX 1.1213
Earnings Per Share (USD) (ttm) 7.5639
Est. EPS (USD) (12/2015) 9.3070
Est. PEG Ratio 1.6296
Market Cap (M USD) 120,514.76
Shares Outstanding (M) 758.86
30 Day Average Volume 3,548,374
Price/Book (mrq) 4.7014
Price/Sale (ttm) 6.0341
Dividend Indicated Gross Yield 1.99%
Cash Dividend (USD) 0.7900
Dividend Ex-Date 02/10/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMGN

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential
More Company Profile & Key Executives for AMGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil